David R Spigel - Tennessee Oncology, PLLC and Sarah Cannon Research Institute

D.R. Spigel, E.P. Korbenfeld, H. Hayashi, R. Corre, B.C. Cho, A. Psyrri,M. Cobo Dols, E. Parkhomenko, D. Baxter, N. Patel,F. Trinchese,I. Diaz-Padilla,M. Reck

Annals of Oncology (2024): S1242-S1243

Cited0Views0Bibtex

Raludotatug Deruxtecan (R-Dxd; DS-6000) in Japanese Patients with Ovarian Cancer: Subgroup Analysis of a Phase 1 Study

K. Sudo,E. P. Hamilton,K. Harano,S. Kitano,K. Takehara,A. Philipovskiy,B. Rini,D. R. Spigel, J. Lin,Y. Okuda,A. Bensmaine, Y. Myobatake,K. Moore

ANNALS OF ONCOLOGY (2024): S1321-S1321

Cited0Views0Bibtex

O13-2 Raludotatug Deruxtecan (R-Dxd; DS-6000) in Japanese Patients with Ovarian Cancer: Subgroup Analysis of a Phase 1 Study

K. Sudo,E.P. Hamilton,K. Harano,S. Kitano,K. Takehara,A. Philipovskiy,B. Rini,D.R. Spigel, J. Lin,Y. Okuda,A. Bensmaine, Y. Myobatake,K. Moore

Annals of Oncology (2024): S1321

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn